Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

被引：490

作者：

Ooft, Salo N. ^{[1
,2
]}

Weeber, Fleur ^{[1
,2
]}

Dijkstra, Krijn K. ^{[1
,2
]}

McLean, Chelsea M. ^{[1
,2
]}

Kaing, Sovann ^{[1
,2
]}

van Werkhoven, Erik ^{[3
]}

Schipper, Luuk ^{[1
,2
]}

Hoes, Louisa ^{[1
,2
]}

Vis, Daniel J. ^{[2
,4
]}

van de Haar, Joris ^{[1
,2
,4
]}

Prevoo, Warner ^{[5
]}

Snaebjornsson, Petur ^{[6
]}

van der Velden, Daphne ^{[1
,2
,16
]}

Klein, Michelle ^{[1
,2
]}

Chalabi, Myriam ^{[1
]}

Boot, Henk ^{[7
]}

van Leerdam, Monique ^{[7
]}

Bloemendal, Haiko J. ^{[8
]}

Beerepoot, Laurens V. ^{[9
]}

Wessels, Lodewyk ^{[2
,4
,10
]}

Cuppen, Edwin ^{[2
,11
,12
]}

Clevers, Hans ^{[2
,13
,14
,15
]}

Voest, Emile E. ^{[1
,2
,7
]}

机构：

[1] Netherlands Canc Inst, Dept Mol Oncol & Immunol, NL-1066 CX Amsterdam, Netherlands

[2] Oncode Inst, NL-3521 AL Utrecht, Netherlands

[3] Netherlands Canc Inst, Dept Biometr, NL-1066 CX Amsterdam, Netherlands

[4] Netherlands Canc Inst, Dept Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands

[5] Netherlands Canc Inst, Dept Radiol, NL-1066 CX Amsterdam, Netherlands

[6] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands

[7] Netherlands Canc Inst, Dept Gastrointestinal Oncol, NL-1066 CX Amsterdam, Netherlands

[8] Radboud Univ Nijmegen, Dept Internal Med Oncol, Med Ctr Nijmegen, NL-6525 GA Nijmegen, Netherlands

[9] Elisabeth TweeSteden Hosp, Dept Internal Med, NL-5042 AD Tilburg, Netherlands

[10] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2628 CD Delft, Netherlands

[11] Univ Med Ctr Utrecht, Ctr Mol Med, Div Biomed Genet, NL-3584 CX Utrecht, Netherlands

[12] Hartwig Med Fdn, NL-1098 XH Amsterdam, Netherlands

[13] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands

[14] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands

[15] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands

[16] Amsterdam Univ Med Ctr AMC, Dept Radiol & Nucl Med, NL-1105 AZ Amsterdam, Netherlands

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2019年 / 11卷 / 513期

关键词：

THYMIDYLATE SYNTHASE EXPRESSION; CLINICAL PHARMACOKINETICS; FLUOROURACIL; OXALIPLATIN; RESISTANCE; QUANTITATION; SENSITIVITY; LANDSCAPE; THERAPY;

D O I：

10.1126/scitranslmed.aay2574

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

There is a clear and unmet clinical need for biomarkers to predict responsiveness to chemotherapy for cancer. We developed an in vitro test based on patient-derived tumor organoids (PDOs) from metastatic lesions to identify nonresponders to standard-of-care chemotherapy in colorectal cancer (CRC). In a prospective clinical study, we show the feasibility of generating and testing PDOs for evaluation of sensitivity to chemotherapy. Our PDO test predicted response of the biopsied lesion in more than 80% of patients treated with irinotecan-based therapies without misclassifying patients who would have benefited from treatment. This correlation was specific to irinotecan-based chemotherapy, however, and the PDOs failed to predict outcome for treatment with 5-fluorouracil plus oxaliplatin. Our data suggest that PDOs could be used to prevent cancer patients from undergoing ineffective irinotecan-based chemotherapy.

引用

页数：9

共 33 条

[1] Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy
Aschele, C
Debernardis, D
Casazza, S
Antonelli, G
Tunesi, G
Baldo, C
Lionetto, R
Maley, F
Sobrero, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1760 - 1770
[2] The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, Jordi
Caponigro, Giordano
Stransky, Nicolas
Venkatesan, Kavitha
Margolin, Adam A.
Kim, Sungjoon
Wilson, Christopher J.
Lehar, Joseph
Kryukov, Gregory V.
Sonkin, Dmitriy
Reddy, Anupama
Liu, Manway
Murray, Lauren
Berger, Michael F.
Monahan, John E.
Morais, Paula
Meltzer, Jodi
Korejwa, Adam
Jane-Valbuena, Judit
Mapa, Felipa A.
Thibault, Joseph
Bric-Furlong, Eva
Raman, Pichai
Shipway, Aaron
Engels, Ingo H.
Cheng, Jill
Yu, Guoying K.
Yu, Jianjun
Aspesi, Peter, Jr.
de Silva, Melanie
Jagtap, Kalpana
Jones, Michael D.
Wang, Li
Hatton, Charles
Palescandolo, Emanuele
Gupta, Supriya
Mahan, Scott
Sougnez, Carrie
Onofrio, Robert C.
Liefeld, Ted
MacConaill, Laura
Winckler, Wendy
Reich, Michael
Li, Nanxin
Mesirov, Jill P.
Gabriel, Stacey B.
Getz, Gad
Ardlie, Kristin
Chan, Vivien
Myer, Vic E.
[J]. NATURE, 2012, 483 (7391) : 603 - 607
[3] XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
Cassidy, J
Tabernero, J
Twelves, C
Brunet, R
Butts, C
Conroy, T
Debraud, F
Figer, A
Grossmann, J
Sawada, N
Schöffski, P
Sobrero, A
Van Cutsem, E
Diaz-Rubio, E
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2084 - 2091
[4] Clinical pharmacokinetics of irinotecan
Chabot, GG
[J]. CLINICAL PHARMACOKINETICS, 1997, 33 (04) : 245 - 259
[5] Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Crystal, Adam S.
Shaw, Alice T.
Sequist, Lecia V.
Friboulet, Luc
Niederst, Matthew J.
Lockerman, Elizabeth L.
Frias, Rosa L.
Gainor, Justin F.
Amzallag, Arnaud
Greninger, Patricia
Lee, Dana
Kalsy, Anuj
Gomez-Caraballo, Maria
Elamine, Leila
Howe, Emily
Hur, Wooyoung
Lifshits, Eugene
Robinson, Hayley E.
Katayama, Ryohei
Faber, Anthony C.
Awad, Mark M.
Ramaswamy, Sridhar
Mino-Kenudson, Mari
Iafrate, A. John
Benes, Cyril H.
Engelman, Jeffrey A.
[J]. SCIENCE, 2014, 346 (6216) : 1480 - 1486
[6] Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Dijkstra, Krijn K.
Cattaneo, Chiara M.
Weeber, Fleur
Chalabi, Myriam
van de Haar, Joris
Fanchi, Lorenzo F.
Slagter, Maarten
van der Velden, Daphne L.
Kaing, Sovann
Kelderman, Sander
van Rooij, Nienke
van Leerdam, Monique E.
Depla, Annekatrien
Smit, Egbert F.
Hartemink, Koen J.
de Groot, Rosa
Wolkers, Monika C.
Sachs, Norman
Snaebjornsson, Petur
Monkhorst, Kim
Haanen, John
Clevers, Hans
Schumacher, Ton N.
Voest, Emile E.
[J]. CELL, 2018, 174 (06) : 1586 - +
[7] Organoids in cancer research
Drost, Jarno
Clevers, Hans
[J]. NATURE REVIEWS CANCER, 2018, 18 (07) : 407 - 418
[8] TFAP2E-DKK4 and Chemoresistance in Colorectal Cancer
Ebert, Matthias P. A.
Taenzer, Marc
Balluff, Benjamin
Burgermeister, Elke
Kretzschmar, Antje Karen
Hughes, David J.
Tetzner, Reimo
Lofton-Day, Catherine
Rosenberg, Robert
Reinacher-Schick, Anke C.
Schulmann, Karsten
Tannapfel, Andrea
Hofheinz, Ralf
Roecken, Christoph
Keller, Gisela
Langer, Rupert
Specht, Katja
Porschen, Rainer
Stoehlmacher-Williams, Jan
Schuster, Tibor
Stroebel, Philipp
Schmid, Roland M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01) : 44 - 53
[9] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Eisenhauer, E. A.
Therasse, P.
Bogaerts, J.
Schwartz, L. H.
Sargent, D.
Ford, R.
Dancey, J.
Arbuck, S.
Gwyther, S.
Mooney, M.
Rubinstein, L.
Shankar, L.
Dodd, L.
Kaplan, R.
Lacombe, D.
Verweij, J.
[J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) : 228 - 247
[10] Precision medicine for cancer with next-generation functional diagnostics
Friedman, Adam A.
Letai, Anthony
Fisher, David E.
Flaherty, Keith T.
[J]. NATURE REVIEWS CANCER, 2015, 15 (12) : 747 - 756

← 1 2 3 4 →